Prevention of Murine Erythropoietic Protoporphyria-Associated Skin Photosensitivity and Liver Disease by Dermal and Hepatic Ferrochelatase
- 1 January 2005
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 124 (1), 256-262
- https://doi.org/10.1111/j.0022-202x.2004.23529.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Erythropoietic protoporphyria: Altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutationsJournal of the American Academy of Dermatology, 2002
- Gene Therapy of a Mouse Model of Protoporphyria with a Self-Inactivating Erythroid-Specific Lentiviral Vector without PreselectionMolecular Therapy, 2001
- Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cellsGene Therapy, 2001
- Reversion of hepatobiliary alterations by bone marrow transplantation in a murine model of erythropoietic protoporphyriaHepatology, 2000
- Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapyNature Medicine, 1999
- Follow-up after liver transplantation for protoporphyric liver diseaseLiver Transplantation and Surgery, 1996
- Ferrochelatase Structural Mutant (Fechm1Pas) in the House MouseGenomics, 1993
- Hemolytic anemia in protoporphyria: Possible precipitating role of liver failure and photic stressAmerican Journal of Hematology, 1992
- Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.JCI Insight, 1991